These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

692 related items for PubMed ID: 9125676

  • 1. Efficacy and proarrhythmia with the use of d,l-sotalol for sustained ventricular tachyarrhythmias.
    Kühlkamp V, Mermi J, Mewis C, Seipel L.
    J Cardiovasc Pharmacol; 1997 Mar; 29(3):373-81. PubMed ID: 9125676
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of d,l-sotalol in patients with ventricular tachycardia and in survivors of cardiac arrest.
    Haverkamp W, Martinez-Rubio A, Hief C, Lammers A, Mühlenkamp S, Wichter T, Breithardt G, Borggrefe M.
    J Am Coll Cardiol; 1997 Aug; 30(2):487-95. PubMed ID: 9247523
    [Abstract] [Full Text] [Related]

  • 3. Suppression of sustained ventricular tachyarrhythmias: a comparison of d,l-sotalol with no antiarrhythmic drug treatment.
    Kühlkamp V, Mewis C, Mermi J, Bosch RF, Seipel L.
    J Am Coll Cardiol; 1999 Jan; 33(1):46-52. PubMed ID: 9935007
    [Abstract] [Full Text] [Related]

  • 4. Long-term efficacy of d/l sotalol in patients with sustained ventricular tachycardia refractory to class I antiarrhythmic drugs.
    Kühlkamp V, Mermi J, Mewis C, Braun U, Seipel L.
    Eur Heart J; 1995 Nov; 16(11):1625-31. PubMed ID: 8881857
    [Abstract] [Full Text] [Related]

  • 5. Reproducible induction of "atypical" torsades de pointes by programmed electrical stimulation: a novel form of sotalol-induced proarrhythmia?
    Krishnan SC, Galvin J, McGovern B, Garan H, Ruskin JN.
    J Cardiovasc Electrophysiol; 1997 Sep; 8(9):1055-61. PubMed ID: 9300303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Female gender as a risk factor for torsades de pointes associated with cardiovascular drugs.
    Makkar RR, Fromm BS, Steinman RT, Meissner MD, Lehmann MH.
    JAMA; 1993 Dec 01; 270(21):2590-7. PubMed ID: 8230644
    [Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of oral sotalol for sustained ventricular tachyarrhythmias refractory to other antiarrhythmic agents.
    Kehoe RF, MacNeil DJ, Zheutlin TA, Ezri MD, Nazari J, Spangenberg RB, Dunnington C, Lueken M.
    Am J Cardiol; 1993 Aug 12; 72(4):56A-66A. PubMed ID: 8346728
    [Abstract] [Full Text] [Related]

  • 9. Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.
    Couderc JP, Kaab S, Hinterseer M, McNitt S, Xia X, Fossa A, Beckmann BM, Polonsky S, Zareba W.
    J Clin Pharmacol; 2009 Jan 12; 49(1):6-16. PubMed ID: 18957528
    [Abstract] [Full Text] [Related]

  • 10. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA, McGovern BA.
    Am J Cardiol; 1996 Aug 29; 78(4A):54-60. PubMed ID: 8780329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Infarct related artery patency: relation to serial electropharmacological studies and outcome in patients with previous myocardial infarction and ventricular tachyarrhythmias.
    Hoppe UC, Haverkamp W, Breithardt G, Borggrefe M.
    Pacing Clin Electrophysiol; 2000 May 29; 23(5):854-62. PubMed ID: 10833706
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports.
    Faber TS, Zehender M, Van de Loo A, Hohnloser S, Just H.
    Clin Cardiol; 1994 Apr 29; 17(4):197-202. PubMed ID: 8187370
    [Abstract] [Full Text] [Related]

  • 15. Torsade de pointes secondary to d,l-sotalol after catheter ablation of incessant atrioventricular reentrant tachycardia--evidence for a significant contribution of the "cardiac memory".
    Haverkamp W, Hördt M, Breithardt G, Borggrefe M.
    Clin Cardiol; 1998 Jan 29; 21(1):55-8. PubMed ID: 9474467
    [Abstract] [Full Text] [Related]

  • 16. Drug-related torsades de pointes in the isolated rabbit heart: comparison of clofilium, d,l-sotalol, and erythromycin.
    Eckardt L, Haverkamp W, Mertens H, Johna R, Clague JR, Borggrefe M, Breithardt G.
    J Cardiovasc Pharmacol; 1998 Sep 29; 32(3):425-34. PubMed ID: 9733356
    [Abstract] [Full Text] [Related]

  • 17. Sotalol proarrhythmia: a report of five cases and an audit of the use of a sotalol in a teaching hospital.
    Basta MN, Leitch JW, Fletcher PJ.
    Aust N Z J Med; 1996 Apr 29; 26(2):167-70. PubMed ID: 8744614
    [Abstract] [Full Text] [Related]

  • 18. Does Sotalol Still Have a Role in the Management of Arrhythmias?
    Semasinghe Bandaralage SP, Nirthanan S, Niranjan S.
    Am J Ther; 2019 Apr 29; 26(1):e161-e169. PubMed ID: 27759583
    [Abstract] [Full Text] [Related]

  • 19. Gastroenteritis with severe consequences: a case of sotalol-induced torsades de pointes.
    Michiels V, Miljoen H, Vrints C.
    Acta Cardiol; 2009 Dec 29; 64(6):839-42. PubMed ID: 20128168
    [Abstract] [Full Text] [Related]

  • 20. Torsades de pointes with a severely prolonged QT interval induced by an initial low dose sotalol intake.
    Yalta K, Turgut O, Yilmaz A, Yilmaz MB, Kendirlioglu O, Karadas F.
    Int J Cardiol; 2007 Apr 04; 116(3):e95-7. PubMed ID: 17126428
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.